|
Markt geschlossen -
Sao Paulo
21:53:50 07.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 41.40 BRL | -16.78% |
|
-3.02% | -27.82% |
| 15:03 | Abbott Laboratories : Barclays bekräftigt seine Kaufempfehlung | ZM |
| 05.10. | Abbott Laboratories erhält FDA-Zulassung für neue Funktionen des CardioMEMS HF Systems | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.58% | -2.20% | -8.86% | +3.24% | -21.20% | -26.18% | +1.91% | -15.25% | +129.76% | 170 Mrd. | |
| -1.81% | -1.81% | -9.20% | +2.95% | -10.98% | -13.13% | +12.34% | -32.18% | -0.51% | 111 Mrd. | |
| -1.01% | -1.21% | -9.15% | -15.19% | -21.64% | -24.81% | +3.59% | +4.43% | +136.09% | 107 Mrd. | |
| -0.03% | +1.42% | -2.10% | -15.03% | -45.67% | -46.89% | -10.61% | -11.16% | +30.47% | 75.95 Mrd. | |
| +0.28% | +3.14% | -4.14% | +6.26% | -6.07% | +3.91% | +72.56% | +171.39% | +295.87% | 60.37 Mrd. | |
| -0.65% | +6.59% | +4.10% | -1.99% | +6.12% | +11.44% | +66.40% | +53.97% | +498.59% | 53.53 Mrd. | |
| -0.08% | -0.99% | -2.48% | +15.83% | -7.17% | -6.16% | -31.35% | -26.54% | +1.72% | 49.11 Mrd. | |
| -1.70% | -2.97% | -2.60% | -11.15% | -25.11% | -19.23% | +14.57% | -18.67% | +339.36% | 40.6 Mrd. | |
| +1.09% | -2.31% | -0.27% | +14.58% | +27.02% | +27.67% | +1.46% | -37.46% | +306.61% | 31.47 Mrd. | |
| -0.28% | +2.16% | +2.19% | -17.58% | -15.60% | - | - | - | - | 31.19 Mrd. | |
| +0.04% | -3.12% | -8.03% | -4.08% | -16.72% | -14.31% | -23.47% | -26.85% | - | 30.65 Mrd. | |
| -1.65% | -2.69% | +7.80% | +2.47% | +33.20% | +36.71% | -2.93% | -11.33% | +389.23% | 26.22 Mrd. | |
| -1.38% | -5.62% | +4.57% | +3.32% | +64.80% | +165.34% | +499.47% | +50.85% | - | 22.91 Mrd. | |
| +1.39% | +0.74% | +14.98% | +21.96% | +4.19% | +10.31% | -4.37% | -51.25% | +236.46% | 23.65 Mrd. | |
| -0.39% | +1.20% | -2.06% | +0.02% | +2.40% | -9.64% | +16.81% | -4.93% | +134.50% | 21.77 Mrd. | |
| +0.49% | -0.46% | -6.64% | -1.69% | -17.29% | -12.87% | -6.49% | -1.19% | +191.26% | 20.34 Mrd. | |
| -0.08% | 0.00% | +7.50% | +21.70% | +21.87% | +13.85% | +16.96% | -26.82% | +82.50% | 18.06 Mrd. | |
| -1.51% | -1.13% | -3.00% | -15.90% | -2.50% | +1.81% | -21.07% | -45.55% | +135.15% | 17.76 Mrd. | |
| -1.33% | -3.12% | -9.77% | -1.41% | -1.59% | -10.46% | -20.21% | -39.53% | -32.34% | 17.11 Mrd. | |
| Durchschnitt | -0.34% | +0.40% | -1.43% | +0.44% | -1.68% | +4.85% | +32.53% | -3.78% | +179.67% | 48.88 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.29% | +0.99% | -4.00% | -0.85% | -10.43% | -8.13% | +20.80% | +0.20% | +157.41% |
- Börse
- Aktien
- 850103 Aktie
- ABTT34 Aktie
- Sektor Abbott Laboratories
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
